TAKAGI Toshio
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Professor and Division head
Article types Original article
Language English
Peer review Peer reviewed
Title Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy.
Journal Formal name:Urologic oncology
Abbreviation:Urol Oncol
ISSN code:10781439
Domestic / ForeginForegin
Volume, Issue, Page 35(9),pp.542.e1-542.e9
Author and coauthor ISHIHARA Hiroki†, KONDO Tsunenori*, YOSHIDA Kazuhiko, OMAE Kenji, TAKAGI Toshio, IIZUKA Junpei, TANABE Kazunari
Publication date 2017/09
DOI 10.1016/j.urolonc.2017.05.014